Limited Stage Small Cell Lung Cancer Clinical Trials in Guangzhou, Guangdong
2 recruitingGuangzhou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
Small Cell Lung CancerLimited Stage Small Cell Lung Cancer
Amgen400 enrolled204 locationsNCT06117774
Recruiting
Phase 2Phase 3
Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
Limited Stage Small Cell Lung Cancer
Sun Yat-sen University346 enrolled1 locationNCT05623267